Dietmar Glogar

Author PubWeight™ 47.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007 2.58
2 Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Radiother Oncol 2006 1.94
3 Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol 2005 1.92
4 Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion. Thromb Haemost 2010 1.58
5 Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study. Eur Heart J 2004 1.48
6 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study. JACC Cardiovasc Interv 2009 1.48
7 The salvage potential of coronary sinus interventions: meta-analysis and pathophysiologic consequences. J Thorac Cardiovasc Surg 2004 1.45
8 Transplant coronary artery disease: Incidence, progression and interventional revascularization. Int J Cardiol 2005 1.41
9 Short- and long-term results of emergency and elective percutaneous interventions on left main coronary artery stenoses. Catheter Cardiovasc Interv 2002 1.40
10 Successful recanalization of a chronic occluded left anterior descending coronary artery with a modification of the retrograde proximal true lumen puncture technique: the antegrade microcatheter probing technique. Catheter Cardiovasc Interv 2009 1.40
11 Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging 2008 1.34
12 Intracoronary thrombectomy with the X-sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome: a prospective, randomized, controlled study. Circulation 2002 1.25
13 Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nat Clin Pract Cardiovasc Med 2008 1.20
14 Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort. Am Heart J 2007 1.18
15 NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study. Circulation 2005 1.11
16 Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. Exp Hematol 2008 1.05
17 Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition. Nat Clin Pract Cardiovasc Med 2008 1.01
18 Arterial compliance: a diagnostic marker for atherosclerotic plaque burden? Am J Hypertens 2003 0.95
19 Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries. Coron Artery Dis 2008 0.94
20 Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Trials 2010 0.92
21 Small vessel stenting with cobalt-chromium stents (Arthos Pico) in a real world setting. Coron Artery Dis 2007 0.91
22 Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients. J Diabetes Complications 2007 0.88
23 Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction. Am Heart J 2007 0.88
24 Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction. Am Heart J 2004 0.87
25 Electromechanical properties of perfusion/metabolism mismatch: comparison of nonfluoroscopic electroanatomic mapping with 18F-FDG PET. J Nucl Med 2004 0.86
26 Active endothelin is an important vasoconstrictor in acute coronary thrombi. Thromb Haemost 2007 0.85
27 A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial. EuroIntervention 2011 0.84
28 Clinical and angiographic analysis with a cobalt alloy coronary stent (driver) in stable and unstable angina pectoris. Am J Cardiol 2006 0.83
29 Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation. Thromb Haemost 2008 0.83
30 Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study. Thromb Haemost 2010 0.82
31 Myocardial protection via the coronary sinus. Circ J 2008 0.81
32 Mechanism of lumen gain during coronary stent deployment in diabetic patients compared with non-diabetic patients. Coron Artery Dis 2002 0.80
33 Characterization of hibernating myocardium with NOGA electroanatomic endocardial mapping. Am J Cardiol 2005 0.80
34 Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting model. Atherosclerosis 2008 0.79
35 Detection of high-grade stenoses with multislice computed tomography in heart transplant patients. J Heart Lung Transplant 2008 0.78
36 Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours. Thromb Haemost 2006 0.78
37 Usefulness of intravascular ultrasound-guided histological measurements after stenting in porcine coronary artery. Coron Artery Dis 2002 0.78
38 Geographical miss during intracoronary irradiation: impact on restenosis and determination of required safety margin length. J Am Coll Cardiol 2002 0.77
39 Plasma levels of IL-6 correlate with hemodynamic abnormalities in acute pancreatitis in rabbits. Intensive Care Med 2002 0.77
40 Vascular remodeling in atherosclerotic femoral arteries: three-dimensional US analysis. Radiology 2004 0.77
41 Prevention of stent thrombosis following brachytherapy and implantation of drug-eluting stents. J Interv Cardiol 2002 0.77
42 Short- and long-term clinical outcome after various stent implantation: overview of the results of uni- and multicenter stent registries. Catheter Cardiovasc Interv 2004 0.77
43 Inhibition of interleukin-1beta convertase is associated with decrease of neointimal hyperplasia after coronary artery stenting in pigs. Mol Cell Biochem 2003 0.76
44 Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid artery. J Endovasc Ther 2011 0.76
45 Clinical quality assurance for endovascular brachytherapy devices. Radiother Oncol 2004 0.76
46 Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention. Catheter Cardiovasc Interv 2014 0.75
47 Valvuloplasty with a paclitaxel-eluting balloon prevents restenosis in an experimental animal model of aortic stenosis. J Heart Valve Dis 2014 0.75
48 Intimal hyperplasia and coronary flow reserve after heart transplantation: association with big endothelin-1. J Heart Lung Transplant 2002 0.75
49 Vascular morphometric changes after radioactive stent implantation: a dose-response analysis. J Am Coll Cardiol 2002 0.75
50 Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries. Coron Artery Dis 2008 0.75
51 [Long-term results of percutaneous transmyocardial laser revascularization therapy at the University of Vienna Medical Center]. Wien Klin Wochenschr 2004 0.75
52 Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients. Radiother Oncol 2005 0.75
53 Duration of development of symptomatic in-stent restenosis correlates with the stent-to-vessel-diameter ratio: an intravascular ultrasound study. Coron Artery Dis 2007 0.75
54 Estimation of doses to personnel and patients during endovascular brachytherapy applications. Radiat Prot Dosimetry 2004 0.75
55 Effects of radial stretch on target lesion revascularization after percutaneous coronary intervention: an intravascular ultrasound study. Can J Cardiol 2003 0.75
56 Serial intravascular ultrasonographic measurements after implantation of biodegradable polymer-coated stents in porcine coronary arteries. Coron Artery Dis 2003 0.75
57 Intracoronary brachytherapy with beta-radiation for the treatment of long diffuse in-stent restenosis. Coron Artery Dis 2004 0.75
58 Increased dosage during intracoronary irradiation due to overlapped source stepping shows no long-term adverse changes in vessel morphology. J Interv Cardiol 2004 0.75
59 Quality assurance in intracoronary brachytherapy. Recommendations for determining the planning target length to avoid geographic miss. Radiother Oncol 2004 0.75
60 Evaluation of myocardial perfusion and left ventricular function six months after percutaneous transmyocardial laser revascularization: comparison of two Ho-YAG laser systems with the same wavelength, but different energy delivery and navigation systems. Lasers Surg Med 2003 0.75
61 Paradoxical effects of aurintricarboxylic acid and RG-13577: acute thrombosis and in-stent stenosis in a passive-coated stent. J Endovasc Ther 2006 0.75
62 Determination and application of the reference isodose length (RIL) for commercial endovascular brachytherapy devices. Radiother Oncol 2002 0.75
63 Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation. Thromb Res 2008 0.75
64 Case-based distance measurements for the selection of controls in case-matched studies: application in coronary interventions. Artif Intell Med 2002 0.75
65 Drug-eluting introducer sheath prevents local peripheral complications: pre-clinical evaluation of nitric oxide-coated sheath. JACC Cardiovasc Interv 2011 0.75
66 Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support. Resuscitation 2002 0.75
67 Basic treatment planning parameters for a 90Sr / 90Y source train used in endovascular brachytherapy. Z Med Phys 2004 0.75